ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/19 | 4,450 | 4,490 | 4,390 | 4,392 | -83 | -1.9% | 404,800 |
| 2025/03/18 | 4,492 | 4,509 | 4,467 | 4,475 | +16 | +0.4% | 276,400 |
| 2025/03/17 | 4,460 | 4,478 | 4,412 | 4,459 | -37 | -0.8% | 300,400 |
| 2025/03/14 | 4,409 | 4,515 | 4,375 | 4,496 | +68 | +1.5% | 380,500 |
| 2025/03/13 | 4,365 | 4,428 | 4,365 | 4,428 | +8 | +0.2% | 241,700 |
| 2025/03/12 | 4,246 | 4,433 | 4,243 | 4,420 | +174 | +4.1% | 495,000 |
| 2025/03/11 | 4,236 | 4,300 | 4,161 | 4,246 | -10 | -0.2% | 765,800 |
| 2025/03/10 | 4,214 | 4,349 | 4,200 | 4,256 | +44 | +1% | 2,102,900 |
| 2025/03/07 | 4,192 | 4,248 | 4,170 | 4,212 | -2 | ±0% | 543,500 |
| 2025/03/06 | 4,303 | 4,313 | 4,206 | 4,214 | -84 | -2% | 488,800 |
| 2025/03/05 | 4,261 | 4,344 | 4,250 | 4,298 | +28 | +0.7% | 590,700 |
| 2025/03/04 | 4,229 | 4,298 | 4,221 | 4,270 | -29 | -0.7% | 1,362,600 |
| 2025/03/03 | 4,310 | 4,347 | 4,267 | 4,299 | +6 | +0.1% | 1,013,400 |
| 2025/02/28 | 4,235 | 4,324 | 4,221 | 4,293 | +56 | +1.3% | 501,400 |
| 2025/02/27 | 4,226 | 4,274 | 4,183 | 4,237 | -14 | -0.3% | 499,100 |
| 2025/02/26 | 4,262 | 4,290 | 4,224 | 4,251 | -20 | -0.5% | 378,000 |
| 2025/02/25 | 4,275 | 4,336 | 4,251 | 4,271 | -45 | -1% | 332,400 |
| 2025/02/21 | 4,300 | 4,360 | 4,270 | 4,316 | -39 | -0.9% | 678,200 |
| 2025/02/20 | 4,410 | 4,415 | 4,326 | 4,355 | -13 | -0.3% | 195,700 |
| 2025/02/19 | 4,381 | 4,418 | 4,368 | 4,368 | -32 | -0.7% | 164,100 |
| 2025/02/18 | 4,493 | 4,504 | 4,362 | 4,400 | -91 | -2% | 178,900 |
| 2025/02/17 | 4,493 | 4,568 | 4,484 | 4,491 | +7 | +0.2% | 245,500 |
| 2025/02/14 | 4,497 | 4,536 | 4,468 | 4,484 | +57 | +1.3% | 284,000 |
| 2025/02/13 | 4,499 | 4,499 | 4,378 | 4,427 | +67 | +1.5% | 280,400 |
| 2025/02/12 | 4,421 | 4,421 | 4,303 | 4,360 | -43 | -1% | 386,000 |
| 2025/02/10 | 4,395 | 4,469 | 4,357 | 4,403 | +78 | +1.8% | 310,800 |
| 2025/02/07 | 4,266 | 4,387 | 4,248 | 4,325 | +59 | +1.4% | 538,600 |
| 2025/02/06 | 4,489 | 4,718 | 4,106 | 4,266 | -196 | -4.4% | 1,034,000 |
| 2025/02/05 | 4,456 | 4,475 | 4,420 | 4,462 | +3 | +0.1% | 175,800 |
| 2025/02/04 | 4,552 | 4,552 | 4,446 | 4,459 | +15 | +0.3% | 214,200 |
| 2025/02/03 | 4,545 | 4,545 | 4,419 | 4,444 | -136 | -3% | 265,300 |
| 2025/01/31 | 4,581 | 4,632 | 4,565 | 4,580 | +5 | +0.1% | 188,500 |
| 2025/01/30 | 4,555 | 4,579 | 4,550 | 4,575 | +14 | +0.3% | 104,900 |
| 2025/01/29 | 4,610 | 4,619 | 4,551 | 4,561 | +6 | +0.1% | 181,600 |
| 2025/01/28 | 4,545 | 4,577 | 4,530 | 4,555 | -5 | -0.1% | 174,200 |
| 2025/01/27 | 4,558 | 4,563 | 4,511 | 4,560 | +32 | +0.7% | 133,700 |
| 2025/01/24 | 4,561 | 4,575 | 4,517 | 4,528 | +15 | +0.3% | 178,800 |
| 2025/01/23 | 4,485 | 4,521 | 4,480 | 4,513 | -5 | -0.1% | 138,800 |
| 2025/01/22 | 4,495 | 4,551 | 4,495 | 4,518 | +13 | +0.3% | 167,900 |
| 2025/01/21 | 4,458 | 4,508 | 4,458 | 4,505 | +36 | +0.8% | 156,500 |
| 2025/01/20 | 4,511 | 4,515 | 4,457 | 4,469 | -42 | -0.9% | 157,000 |
| 2025/01/17 | 4,480 | 4,558 | 4,480 | 4,511 | +33 | +0.7% | 130,300 |
| 2025/01/16 | 4,515 | 4,537 | 4,478 | 4,478 | -37 | -0.8% | 144,200 |
| 2025/01/15 | 4,560 | 4,572 | 4,494 | 4,515 | -61 | -1.3% | 203,100 |
| 2025/01/14 | 4,630 | 4,645 | 4,558 | 4,576 | -80 | -1.7% | 205,600 |
| 2025/01/10 | 4,684 | 4,701 | 4,648 | 4,656 | -54 | -1.1% | 214,000 |
| 2025/01/09 | 4,712 | 4,729 | 4,672 | 4,710 | -2 | ±0% | 144,300 |
| 2025/01/08 | 4,686 | 4,728 | 4,673 | 4,712 | +9 | +0.2% | 145,300 |
| 2025/01/07 | 4,685 | 4,775 | 4,680 | 4,703 | +28 | +0.6% | 214,800 |
| 2025/01/06 | 4,737 | 4,747 | 4,674 | 4,675 | -33 | -0.7% | 178,400 |
151～
200
件表示中 / 3812件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 350,400円 | +3.8% | -19.9% | 3.88% | 11.38倍 | 0.87倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 参天薬 | 145,950円 | -2.0% | -7.3% | 2.60% | 13.92倍 | 1.65倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 394,500円 | +5.8% | +1.2% | 3.04% | 12.68倍 | 1.05倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 日本新薬 | 321,200円 | +3.6% | -15.3% | 3.86% | 9.02倍 | 0.87倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サワイＧＨＤ | 183,400円 | +5.9% | +684.6% | 3.00% | 12.17倍 | 1.21倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
市場注目の銘柄
チャート関連のコラム
